Business Description: Novotech is internationally recognized as the leading regional full-service contract research organization (CRO) in Asia-Pacific and has been instrumental in the success of over 1,200 Phase I - IV clinical trials for biotechnology companies. Recently awarded the Frost & Sullivan 2020 Frost & Sullivan Asia-Pacific CRO Company of the Year, Novotech was established in 1996, with offices in 11 locations across the region, and site partnerships with major health institutions. We provide clinical development services across all clinical trial phases and therapeutic areas, including an in-house and integrated global product development and regulatory affairs consultancy, BioDesk. BioDesk can intelligently guide client’s products from bench to market through CMC/manufacturing, toxicology, clinical and regulatory affairs consulting services. We work in a fast paced and adaptable environment allowing us to bring best in class solutions and services to our clients setting a high benchmark for clinical trial operations by listening carefully, allocating Asia Pacific’s best people and talent, and leveraging best in class platforms, technology, systems and processes to meet our client’s clinical program goals and ultimately improve patient lives.